BlackRock Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.86M | Buy |
134,794
+12,972
| +11% | +$179K | ﹤0.01% | 1498 |
|
|
2016
Q3 | $2.2M | Buy |
121,822
+100,969
| +484% | +$1.82M | ﹤0.01% | 1381 |
|
|
2016
Q2 | $299K | Buy |
20,853
+996
| +5% | +$14.3K | ﹤0.01% | 2364 |
|
|
2016
Q1 | $237K | Buy |
19,857
+1,337
| +7% | +$16K | ﹤0.01% | 2430 |
|
|
2015
Q4 | $247K | Sell |
18,520
-8,559
| -32% | -$114K | ﹤0.01% | 2423 |
|
|
2015
Q3 | $291K | Sell |
27,079
-38,895
| -59% | -$418K | ﹤0.01% | 2481 |
|
|
2015
Q2 | $531K | Buy |
65,974
+43,027
| +188% | +$346K | ﹤0.01% | 2103 |
|
|
2015
Q1 | $152K | Buy |
22,947
+3,814
| +20% | +$25.3K | ﹤0.01% | 2810 |
|
|
2014
Q4 | $122K | Sell |
19,133
-701
| -4% | -$4.47K | ﹤0.01% | 2896 |
|
|
2014
Q3 | $196K | Sell |
19,834
-785
| -4% | -$7.76K | ﹤0.01% | 2591 |
|
|
2014
Q2 | $232K | Sell |
20,619
-3,028
| -13% | -$34.1K | ﹤0.01% | 2508 |
|
|
2014
Q1 | $286K | Buy |
23,647
+1,492
| +7% | +$18K | ﹤0.01% | 2410 |
|
|
2013
Q4 | $279K | Buy |
22,155
+1,965
| +10% | +$24.7K | ﹤0.01% | 2423 |
|
|
2013
Q3 | $336K | Sell |
20,190
-5,004
| -20% | -$83.3K | ﹤0.01% | 2191 |
|
|
2013
Q2 | $383K | Buy |
+25,194
| New | +$383K | ﹤0.01% | 2021 |
|